ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ZIVO Zivo Bioscience Inc (QB)

7.90
0.00 (0.00%)
06 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Zivo Bioscience Inc (QB) USOTC:ZIVO OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 7.90 5.00 9.05 122 21:04:43

Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting

18/09/2014 6:44pm

PR Newswire (US)


Zivo Bioscience (QB) (USOTC:ZIVO)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Zivo Bioscience (QB) Charts.

KEEGO HARBOR, Mich., Sept. 18, 2014 /PRNewswire/ -- Health Enhancement Products, Inc. (OTCQB: HEPI), a Michigan-based biotech firm investigating early-stage algae bioactive compounds and metabolic processes, is pleased to announce the addition of a new member to the company's board of directors. Ms. Nola E. Masterson, a California-based biotech executive and investment advisor joined the board effective September 17, 2014.

"We're very pleased and honored to have Ms. Masterson agree to join our board," states Andrew Dahl, President and CEO. "She joins us at an important inflection point in the company's growth trajectory. Her extensive knowledge and experience in life science finance and operations is an invaluable resource for all involved. Her experience as an analyst, investment advisor, executive and entrepreneur will greatly benefit the company."

Ms. Masterson, who resides in Woodside, California, has an extensive and well-regarded track record in the biotech industry. Since 1982, she has been the Chief Executive Officer of Science Futures Inc., an investment and advisory firm, and is currently Managing Member and General Partner of Science Futures LLC, I and II, which are venture capital funds invested in life science funds and companies. As Board Chair of Repros Therapeutics, Inc., Ms. Masterson also serves on the audit committee, nominating committee and compensation committee. She was the first biotechnology analyst on Wall Street, working with Drexel Burnham Lambert and Merrill Lynch, and is a co-founder of Sequenom, Inc., a genetic analysis company located in San Diego and Hamburg, Germany. Ms. Masterson is the Chair Emeritus of the Bay Bio Institute, a 501(c)3 affiliate of BayBio, which promotes science education, workforce development and best practices as well as entrepreneurs in the bioeconomy.

Her business career began at Ames Company, a division of Bayer, and was followed by eight years at Millipore Corporation in sales and sales management. Ms. Masterson has 33 years of experience in the life science industry. She received her Masters' degree in Biological Sciences from George Washington University, and continued Ph.D. coursework at the University of Florida.

About Health Enhancement Products, Inc.

Health Enhancement Products, Inc. (OTCQB: HEPI) is a Michigan-based biotech company engaged in the investigation of the health benefits of early-stage bioactive compounds, the development of natural bioactive compounds for use as dietary supplements and food ingredients, as well as convergence products in the field of metabolomics.

SOURCE Health Enhancement Products, Inc.

Copyright 2014 PR Newswire

1 Year Zivo Bioscience (QB) Chart

1 Year Zivo Bioscience (QB) Chart

1 Month Zivo Bioscience (QB) Chart

1 Month Zivo Bioscience (QB) Chart

Your Recent History

Delayed Upgrade Clock